scholarly journals The effectiveness of the World Anti-Doping Agency: developing a framework for analysis

2018 ◽  
Vol 11 (2) ◽  
pp. 203-217 ◽  
Author(s):  
Barrie Houlihan ◽  
Dag Vidar Hanstad
Author(s):  
Thomas M. Hunt

Performance enhancement in sport has a long and controversial history. Although several organizations enacted prohibitions on the subject of doping prior to the Second World War, public scrutiny on the issue remained relatively light until the second half of the twentieth century. Beginning in the 1960s, officials passed a number of regulatory measures with the twin goals of protecting the health of athletes and ensuring the fairness of competitions. Due partially to the effects of Cold War political rivalries, the use of drugs by athletes nevertheless remained widespread in the world of sport. This policy situation changed dramatically with the end of the superpower conflict in 1991, however. The following decade was marked by increasingly vociferous calls for reform from outside the international governance structure for sport. In February of 1999, regulatory powers over the subject were centralized in a new organization called the World Anti-Doping Agency (WADA).


2018 ◽  
Vol 55 (3) ◽  
pp. 251-271 ◽  
Author(s):  
Tien-Chin Tan ◽  
Alan Bairner ◽  
Yu-Wen Chen

With the problems of doping in sport becoming more serious, the World Anti-Doping Code was drafted by the World Anti-Doping Agency in 2003 and became effective one year later. Since its passage, the Code has been renewed four times, with the fourth and latest version promulgated in January 2015. The Code was intended to tackle the problems of doping in sports through cooperation with governments to ensure fair competition as well as the health of athletes. To understand China’s strategies for managing compliance with the Code and also the implications behind those strategies, this study borrows ideas from theories of compliance. China’s high levels of performance in sport, judged by medal success, have undoubtedly placed the country near the top of the global sports field. Therefore, how China acts in relation to international organizations, and especially how it responds to the World Anti-Doping Agency, is highly significant for the future of elite sport and for the world anti-doping regime. Through painstaking efforts, the researchers visited Beijing to conduct field research four times and interviewed a total of 22 key sports personnel, including officials at the General Administration of Sports of China, the China Anti-Doping Agency, and individual sport associations, as well as sport scholars and leading officials of China’s professional sports leagues. In response to the World Anti-Doping Agency, China developed strategies related to seven institutional factors: ‘monitoring’, ‘verification’, ‘horizontal linkages’, ‘nesting’, ‘capacity building’, ‘national concern’ and ‘institutional profile’. As for the implications, the Chinese government is willing and able to comply with the World Anti-Doping Agency Code. In other words, the Chinese government is willing to pay a high price in terms of money, manpower and material resources so that it can recover from the disgrace suffered as a result of doping scandals in the 1990s. The government wants to ensure that China’s prospects as a participant, bidder and host of mega sporting events are not compromised, especially as the host of the 2022 Winter Olympics in Beijing.


2017 ◽  
Vol 63 (3) ◽  
pp. 110-114
Author(s):  
Alexandru Robert Vlad ◽  
Andreea Ioana Lungu

AbstractAttention-deficit–hyperactivity disorder (ADHD) is a common neuropsychiatric disorder that impairs academic, social and occupational functioning in children, adolescents and adults. It is characterized by excessive activity, restlessness, and nervousness. The disease occurs in general at children before the age of 7 and usually is not easy to be detected, due to various symptoms. When the diagnosis is established the physician can prescribe two types of drugs, stimulants: amphetamine, dexamphetamine, lisdexamphetamine, methylphenidate, and non-stimulants such as: guanfacine, atomoxetine, and clonidine. So what can be done for a person who has ADHD, and wants to be an elite athlete? Due to the rules established by the World Anti-Doping Agency the stimulant drugs are prohibited in competition and if traces of a prohibited substance are detected in the sample of blood of the athlete his access to competition can be blocked from 2-4 years, from that date of the incident. Fortunately for some athletes the disease was acute in childhood but as they grew up the symptoms were reminiscent and they could concentrate at the sporting task that was supposed to be achieved. What about those athletes that still have the symptoms? Well, they can be treated with the non-stimulant drugs, but their doctor must monthly verify if the list of prohibited drugs has been changed. In conclusion we can say that ADHD can be an impediment, but with the help of parents, teachers, and physicians the athlete can achieve very good performances.


Philosophies ◽  
2019 ◽  
Vol 4 (3) ◽  
pp. 35
Author(s):  
Francisco Javier Lopez Frias

(1) Background: The World Anti-Doping Agency (WADA) utilizes three criteria to include a technology in the List of Banned Substances and Methods—performance enhancement, health, and the spirit of sport. The latter is arguably the most fundamental one, as WADA justifies the anti-doping mission by appealing to it. (2) Method: Given the interrelationship among the notions of “human nature,” “natural talent,” and “sport,” I investigate what view of human nature underpins the “spirit of sport” criterion. To do so, I focus on both WADA’s official documents and scholarly formulations of the spirit of sport (that align with that of WADA). (3) Results: I show that the value attributed to excellence and effort in WADA’s formulation of the “spirit of sport” criterion has its roots in the notion of human nature of the work ethic that resulted from the secularization of the Protestant ethic. (4) Conclusion: Drawing on my analysis of the “spirit of sport” criterion, I pose critical questions concerning the justification of WADA’s anti-doping campaign and a tentative solution to move forward in the debate.


Bioanalysis ◽  
2020 ◽  
Author(s):  
Michele Protti ◽  
Roberto Mandrioli ◽  
Laura Mercolini

Background. Systemic glucocorticoids are prohibited in-competition by the World Anti-Doping Agency. Here, we describe an original microsampling workflow for the quantitation of three endogenous (cortisol, corticosterone and cortisone) and three exogenous (dexamethasone, methylprednisolone and fludrocortisone) corticosteroids in 30 μl of human urine. Materials & methods. Microsampling was carried out by dried urine spot (DUS) sampling and volumetric absorptive microsampling (VAMS), followed by solvent extraction and LC–MS/MS analysis. Results & conclusion: Good linearity (r2 > 0.9989) was obtained for all analytes; extraction yields (>81%), precision (RSD < 8.6%) and matrix effect (<12%) were satisfactory. Microsample stability at room temperature was good (analyte loss <15% after 3 months). Data obtained from real urine microsample analysis were compared with those of fluid urine, providing very good agreement (r2 > 0.9991).


2018 ◽  
Vol 4 (1) ◽  
pp. 18-29
Author(s):  
Ian Ritchie ◽  
Kathryn Henne

Purpose The purpose of this paper is to assess the institutional mechanisms for combating doping in high-level sport, including the trend toward using legalistic frameworks, and how they contribute to notions of deviance. Design/methodology/approach A historical approach informed by recent criminological adaptations of genealogy was utilized, using primary and secondary sources. Findings Three time periods involving distinct frameworks for combating doping were identified, each with their own advantages and limitations: pre-1967, post-1967 up until the creation of the World Anti-Doping Agency in 1999, and post-1999. Originality/value This study contextualizes the recent legalistic turn toward combating doping in sport, bringing greater understanding to the limitations of present anti-doping practices.


2020 ◽  
pp. 101269022097735
Author(s):  
Fabien Ohl ◽  
Lucie Schoch ◽  
Bertrand Fincoeur

The World Anti-Doping Agency (WADA) and the International Olympic Committee (IOC) have been held accountable for the “Russian crisis,” a major state-sponsored doping scandal, which began in 2014. The scandal has brought intense scrutiny on the IOC’s and WADA’s efficiency in curbing doping. This paper argues that their impaired credibility should not only be explained through their objective failure in preventing doping in Russia but can be mainly understood through an analysis of their staged promises of clean sport. This study relies on the analysis of a corpus of official policy documents from the IOC and WADA over the last two decades, several media sources, and field-notes from our “participant-as-observer” role during several anti-doping meetings. In the first part of this article, we argue that to convince the audiences of their commitment to the fight against doping, WADA and the IOC collaborate to create a “team presentation” in which “impression management” is used to stage promises of a strong anti-doping doxa. The second part of the article elaborates that performances are vulnerable and complicated. Because of its scale, the Russian crisis disrupted the IOC’s and WADA’s dramaturgy, revealing their individual agendas and their rivalries over the control of the doxa, with the IOC seeking to protect its power and WADA trying to remain a “trust device.” Finally, the article shows that the IOC and WADA trapped themselves within their own staged discourse because of their divisions and their outbidding promises of clean sport, which turned ineffective and even “toxic.” We conclude that such a scenario was detrimental to the overall anti-doping efforts and the subsequent credibility of these organizations.


Blood ◽  
2011 ◽  
Vol 118 (9) ◽  
pp. 2395-2404 ◽  
Author(s):  
Wolfgang Jelkmann ◽  
Carsten Lundby

AbstractHemoglobin mass is a key factor for maximal exercise capacity. Some athletes apply prohibited techniques and substances with intent to increase hemoglobin mass and physical performance, and this is often difficult to prove directly. Autologous red blood cell transfusion cannot be traced on reinfusion, and also recombinant erythropoietic proteins are detectable only within a certain timeframe. Novel erythropoietic substances, such as mimetics of erythropoietin (Epo) and activators of the Epo gene, may soon enter the sports scene. In addition, Epo gene transfer maneuvers are imaginable. Effective since December 2009, the World Anti-Doping Agency has therefore implemented “Athlete Biologic Passport Operating Guidelines,” which are based on the monitoring of several parameters for mature red blood cells and reticulocytes. Blood doping may be assumed, when these parameters change in a nonphysiologic way. Hematologists should be familiar with blood doping practices as they may play an important role in evaluating blood profiles of athletes with respect to manipulations, as contrasted with the established diagnosis of clinical disorders and genetic variations.


Sign in / Sign up

Export Citation Format

Share Document